Chronic Propranolol Treatment in Young Spontaneously Hypertensive and Normotensive Rats

1973 ◽  
Vol 51 (10) ◽  
pp. 727-732 ◽  
Author(s):  
I. Vávra ◽  
H. Tom ◽  
E. Greselin

Oral treatment with propranolol, 1 or 5 mg/kg per day, was started in young spontaneously hypertensive rats (S.H.R.) 1 week after weaning and continued for 12 weeks. The same doses were administered to age-matched normotensive rats. Propranolol was admixed to a standard laboratory diet in concentrations calculated on the basis of average food consumption. Blood pressure was measured by an indirect method.As compared to control S.H.R., a significantly lower blood pressure was recorded in S.H.R. treated with propranolol, 1 mg/kg, at week 10 and 12 of the treatment and in those treated with 5 mg/kg at weeks 6–12. The heart rate was not consistently affected.The blood pressure of control and treated normotensive rats did not differ significantly with the exception of an elevated blood pressure in both dosage groups at the first reading.The growth of rats was not impaired by propranolol and no morphological organ changes related to the treatment could be detected at the end of the experiment.

Pharmacology ◽  
2011 ◽  
Vol 87 (5-6) ◽  
pp. 257-264 ◽  
Author(s):  
Zhih-Cherng Chen ◽  
Ja-Ping Shieh ◽  
Hsien-Hui Chung ◽  
Ching-Hsia Hung ◽  
Hung Jung Lin ◽  
...  

1996 ◽  
Vol 271 (3) ◽  
pp. H1132-H1138 ◽  
Author(s):  
R. A. Johnson ◽  
M. Lavesa ◽  
K. DeSeyn ◽  
M. J. Scholer ◽  
A. Nasjletti

Heme oxygenase catalyzes the metabolism of heme to biliverdine, free iron, and carbon monoxide. The current study was designed to determine if treatment with the heme oxygenase substrates heme-L-arginate or heme-L-lysinate, to stimulate formation of heme oxygenase products, can lower blood pressure in the rat. Heme-L-arginate (45 mumol/kg ip) and heme-L-lysinate (45 mumol/kg ip) acutely lowered blood pressure in awake spontaneously hypertensive rats (SHR) by approximately 35 mmHg. For both heme oxygenase substrates, this effect was blunted by pretreatment with an inhibitor of heme oxygenase, zinc deuteroporphyrin 2,4-bis glycol. Heme-L-lysinate also lowered arterial pressure in deoxycorticosterone acetate-salt hypertensive rats and in rats with phenylephrine-induced hypertension, indicating that the vasodepressive actions of heme may be extended to other hypertensive models. However, neither heme-L-arginate nor heme-L-lysinate decreased blood pressure in normotensive controls. The heme oxygenase product biliverdine did not lower blood pressure in SHR, and the vasodepressive actions of heme-L-lysinate were unaffected by pretreatment with deferoxamine to chelate free iron. Carbon monoxide (12 ml/kg ip) lowered blood pressure in SHR and in rats made hypertensive by phenylephrine infusion, had no effect on blood pressure in Wistar-Kyoto rats, and elicited only a modest vasodepressive response in normotensive Sprague-Dawley rats. We conclude that heme-bearing preparations can lower blood pressure in hypertensive rats, presumably via heme oxygenase-mediated formation of carbon monoxide.


Hypertension ◽  
1992 ◽  
Vol 19 (6_pt_2) ◽  
pp. 668-671 ◽  
Author(s):  
M J DePasquale ◽  
A A Fossa ◽  
W F Holt ◽  
M L Mangiapane

2009 ◽  
Vol 29 (2) ◽  
pp. 130-138 ◽  
Author(s):  
Kevin S. Shaughnessy ◽  
Ian A. Boswall ◽  
Adam P. Scanlan ◽  
Katherine T. Gottschall-Pass ◽  
Marva I. Sweeney

Sign in / Sign up

Export Citation Format

Share Document